Wealthfront Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Sell |
853
-6
| -0.7% | -$1.72K | ﹤0.01% | 910 |
|
|
2025
Q1 | $265K | Sell |
859
-26
| -3% | -$8.02K | ﹤0.01% | 863 |
|
|
2024
Q4 | $312K | Buy |
885
+9
| +1% | +$3.18K | ﹤0.01% | 830 |
|
|
2024
Q3 | $314K | Sell |
876
-29
| -3% | -$10.4K | ﹤0.01% | 828 |
|
|
2024
Q2 | $288K | Buy |
+905
| New | +$288K | ﹤0.01% | 816 |
|
|
2023
Q1 | – | Sell |
-795
| Closed | -$221K | – | 821 |
|
|
2022
Q4 | $221K | Buy |
+795
| New | +$221K | ﹤0.01% | 760 |
|
|
2022
Q1 | – | Sell |
-1,261
| Closed | -$272K | – | 818 |
|
|
2021
Q4 | $272K | Buy |
1,261
+172
| +16% | +$37.1K | ﹤0.01% | 698 |
|
|
2021
Q3 | $201K | Buy |
+1,089
| New | +$201K | ﹤0.01% | 687 |
|